Russia's Human Stem Cell Institute has announced that it is seeking funding from investors in what promises to be Russia's first initial public offering in over a year.
While other countries are still trying to figure out what their federal regulatory laws should be, India is providing a fertile, friendly, and profitable market for new adult stem cell companies.
Another ailing dog benefits from autologous adult stem cell therapy.
Once again, the successful use of autologous adult stem cells for the treatment of animals is in the news.
Once again, autologous adult stem cell therapy is successfully used to treat man's best friend.
Biotech giant Novartis agrees to pay $4 million to Opexa Therapeutics for its proprietary adult stem cell technology.
Vetrinarians in Austin, Texas are among the growing number of humans who are discovering that adult stem cell therapies are for the dogs.
Researchers in Japan discover a natural "biological pacemaker" in adult stem cells derived from adipose tissue.
The biotech company NeoStem is featured on the CBS Sunday morning segment, "Eye on New York City", for their pioneering work with adult stem cells.
The biotech company Stem Cell Therapeutics begins enrollment in a Phase IIb clinical trial for acute ischemic stroke.